From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Drug commercialization continues to be a challenge for pharmaceutical manufacturers of all sizes and complexities. Whether you’re bringing your first drug to market or entering a new therapeutic category, determining the optimal market access strategies and putting them into action often takes more time, resources, and expertise than you’ve got on-hand. IntegriChain, together with Blue Fin Group, an IntegriChain Company, solves that problem across the full range of product archetypes, from generics to cell and gene therapy, from traditional brand to biosimilars and orphan and rare disease.
Our life science consulting, integration, and implementation services enable us to address your entire spectrum of commercialization and access challenges.
Strategy Consulting
Learn More
Build a complete plan, tailored by product archetype
Understand and assess impact pricing implications
Achieve balance between pricing and contracting over the long-term of a product’s life
Designing pharmacy and provider strategies across all therapeutic areas and drug classes
Guidance to improve patient pull through
Design and negotiate agreements
Patient, prescriber, pharmacy, payer Insights
Operational Consulting
Proven blueprint to launch success
Performance metrics based on industry’s largest data set
Helping execute even the most complex contracting strategies
Gross-to-Net insights at your fingertips
Making data-driven market access a reality
Integration & Implementation
Upgrades, mergers, support, and transitions of enterprise software systems
Data governance, mastering, and unification
Insights into patient interventions, conversions, and more
Accelerate design-making with rapid data visualizations
From the first launch to ongoing market access operational execution, IntegriChain’s life science consulting team is capable of solving some of the most complex and pressing challenges associated with drug commercialization. IntegriChain delivers Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization
let’s talk
A top 10 pharmaceutical manufacturer was preparing to launch a complex oncology combination regimen with two novel agents but was faced with several unique commercial challenges.
Read the Case Study
From helping emerging companies plan and execute their first-time launch to supporting more than 65% of the top-50 largest manufacturers, IntegriChain’s consulting services enable manufacturers to get their therapies to the right patients at the right time.
Download Now
